Strain Name:

FVB.129(B6)-Smn1tm5(Smn1/SMN2)Mrph/J

Stock Number:

008604

Order this mouse

Availability:

Repository- Live

Use Restrictions Apply, see Terms of Use
The hybrid allele in this strain, Smn allele C, contains two tandem Smn1/SMN2 genes. Further characterization is currently in progress. This mutant mouse strain may be useful in studies of Spinal Muscular Atrophy.

Description

Strain Information

Type Congenic; Mutant Strain; Targeted Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Additional information on Congenic nomenclature.
Mating SystemHomozygote x Heterozygote         (Female x Male)   05-MAR-12
Specieslaboratory mouse
GenerationN8 (25-MAR-11)
Generation Definitions
 
Donating Investigator IMR Colony,   The Jackson Laboratory

Description
The hybrid allele in this strain, Smn allele C, contains two tandem Smn1/SMN2 genes. Further characterization is currently in progress. This mutant mouse strain may be useful in studies of Spinal Muscular Atrophy.

Development of this model was supported by the Spinal Muscular Atrophy Foundation.

Development
This mutant mouse carries the Smn allele C, which contains two tandem Smn1/SMN2 genes. The first is a hybrid gene in which a 2.2 kb segment of mouse genome containing exons 7 and 8 of the mouse Smn1 gene was replaced with a 1.3 kb fragment of human genomic DNA containing exons 7 and 8 of the human SMN2 gene. The second is a full 42 kb copy of the human SMN2 gene. A selection cassette located downstream from the human SMN2 polyadenylation signal was removed by FLPe expression in ES cells leaving a FRT site at the downstream junction between human and mouse DNA. Because exon 7 is derived from human SMN2, it is skipped in approximately 90% of the processed mRNA derived from both genes. The 129S6/SvEvTac X C57BL/6Tac hybrid derived ES cell line F1H4 was used. The mice were crossed to C57BL/6J once, and then were backcrossed to FVB/NJ using a speed congenic protocol.

Control Information

  Control
   Wild-type from the colony
   001800 FVB/NJ
 
  Considerations for Choosing Controls

Related Strains

Spinal Muscular Atrophy (SMA) Models
008849   B6.129(C)-Smn1tm1.1Jme/J
006146   B6.129-Smn1tm1Jme/J
008453   B6.129-Smn1tm4(SMN2)Mrph/J
008714   B6.129-Smn1tm5(Smn1/SMN2)Mrph/J
009378   B6.129-Smn1tm6(SMN2)Mrph/J
018439   B6.129S6-Tg(CAG-Bgeo,-SMN2)E9Dscd/J
009680   B6.B-Vps54wr/J
007963   B6.Cg-Smn1tm2Mrph/J
007966   B6.Cg-Smn1tm3(SMN2/Smn1)Mrph/J
006149   B6.Cg-Tg(ACTA1-cre)79Jme/J
006663   B6.Cg-Tg(Eno2-cre)39Jme/J
008629   B6.Cg-Tg(SMN2)11Tro Smn1tm1Msd/J
008631   B6.Cg-Tg(SMN2)11Tro Tg(SMN2)46Tro Smn1tm1Msd/J
008630   B6.Cg-Tg(SMN2)46Tro Smn1tm1Msd/J
007246   B6;129-Smn1tm2Mrph/J
008383   B6;129-Smn1tm4(SMN2)Mrph/J
008384   B6;129-Smn1tm5(Smn1/SMN2)Mrph/J
008704   B6;129-Smn1tm6(SMN2)Mrph/J
006138   FVB.129(B6)-Smn1tm1Jme/J
008713   FVB.129(B6)-Smn1tm4(SMN2)Mrph/J
005058   FVB.Cg-Smn1tm1Hung Tg(SMN2)2Hung/J
016573   FVB.Cg-Smn1tm1Msd Tg(S100B-EGFP)1Wjt Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb/J
008209   FVB.Cg-Smn1tm1Msd Tg(ACTA1-SMN)69Ahmb Tg(SMN2)89Ahmb/J
008206   FVB.Cg-Smn1tm1Msd Tg(SMN2)566Ahmb/J
008782   FVB.Cg-Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*A111G)588Ahmb/J
009134   FVB.Cg-Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*A111G)591Ahmb/J
006214   FVB.Cg-Smn1tm1Msd/J
007955   FVB.Cg-Smn1tm2Mrph/J
007964   FVB.Cg-Smn1tm3(SMN2/Smn1)Mrph/J
009381   FVB.Cg-Smn1tm6(SMN2)Mrph/J
012252   FVB.Cg-Tbcepmn/J
006139   FVB.Cg-Tg(ACTA1-cre)79Jme/J
006297   FVB.Cg-Tg(Eno2-cre)39Jme/J
005024   FVB.Cg-Tg(SMN2)89Ahmb Smn1tm1Msd/J
005026   FVB.Cg-Tg(SMN2)89Ahmb Tg(SMN1*A2G)2023Ahmb Smn1tm1Msd/J
005025   FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd/J
009682   NMRI-Tbcepmn/J
017596   STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#aAhmb/J
017597   STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#bAhmb/J
007022   STOCK Mnx1tm4(cre)Tmj Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008203   STOCK Smn1tm1Msd Tg(ACTA1-SMN)63Ahmb Tg(SMN2)89Ahmb/J
006570   STOCK Smn1tm1Msd Tg(Hlxb9-GFP)1Tmj Tg(SMN2)89Ahmb/J
006553   STOCK Smn1tm1Msd Tg(H2-K1-tsA58)6Kio Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008212   STOCK Smn1tm1Msd Tg(Prnp-SMN)92Ahmb Tg(SMN2)89Ahmb/J
007951   STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008783   STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Tg(CAG-cre/Esr1*)5Amc/J
005938   STOCK Tg(Eno2-cre)39Jme/J
017599   STOCK Tg(tetO-SMN2,-luc)#aAhmb/J
017600   STOCK Tg(tetO-SMN2,-luc)#bAhmb/J
View Spinal Muscular Atrophy (SMA) Models     (49 strains)

Strains carrying   Smn1tm5(Smn1/SMN2)Mrph allele
008714   B6.129-Smn1tm5(Smn1/SMN2)Mrph/J
008384   B6;129-Smn1tm5(Smn1/SMN2)Mrph/J
View Strains carrying   Smn1tm5(Smn1/SMN2)Mrph     (2 strains)

Strains carrying other alleles of SMN2
008453   B6.129-Smn1tm4(SMN2)Mrph/J
009378   B6.129-Smn1tm6(SMN2)Mrph/J
018439   B6.129S6-Tg(CAG-Bgeo,-SMN2)E9Dscd/J
008629   B6.Cg-Tg(SMN2)11Tro Smn1tm1Msd/J
008631   B6.Cg-Tg(SMN2)11Tro Tg(SMN2)46Tro Smn1tm1Msd/J
008630   B6.Cg-Tg(SMN2)46Tro Smn1tm1Msd/J
008383   B6;129-Smn1tm4(SMN2)Mrph/J
008704   B6;129-Smn1tm6(SMN2)Mrph/J
008713   FVB.129(B6)-Smn1tm4(SMN2)Mrph/J
005058   FVB.Cg-Smn1tm1Hung Tg(SMN2)2Hung/J
016573   FVB.Cg-Smn1tm1Msd Tg(S100B-EGFP)1Wjt Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb/J
008209   FVB.Cg-Smn1tm1Msd Tg(ACTA1-SMN)69Ahmb Tg(SMN2)89Ahmb/J
008206   FVB.Cg-Smn1tm1Msd Tg(SMN2)566Ahmb/J
008782   FVB.Cg-Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*A111G)588Ahmb/J
009134   FVB.Cg-Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*A111G)591Ahmb/J
009381   FVB.Cg-Smn1tm6(SMN2)Mrph/J
005024   FVB.Cg-Tg(SMN2)89Ahmb Smn1tm1Msd/J
005026   FVB.Cg-Tg(SMN2)89Ahmb Tg(SMN1*A2G)2023Ahmb Smn1tm1Msd/J
005025   FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd/J
017596   STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#aAhmb/J
017597   STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#bAhmb/J
007022   STOCK Mnx1tm4(cre)Tmj Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008203   STOCK Smn1tm1Msd Tg(ACTA1-SMN)63Ahmb Tg(SMN2)89Ahmb/J
006570   STOCK Smn1tm1Msd Tg(Hlxb9-GFP)1Tmj Tg(SMN2)89Ahmb/J
006553   STOCK Smn1tm1Msd Tg(H2-K1-tsA58)6Kio Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008212   STOCK Smn1tm1Msd Tg(Prnp-SMN)92Ahmb Tg(SMN2)89Ahmb/J
007951   STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008783   STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Tg(CAG-cre/Esr1*)5Amc/J
017599   STOCK Tg(tetO-SMN2,-luc)#aAhmb/J
017600   STOCK Tg(tetO-SMN2,-luc)#bAhmb/J
View Strains carrying other alleles of SMN2     (30 strains)

Strains carrying other alleles of Smn1
008849   B6.129(C)-Smn1tm1.1Jme/J
006146   B6.129-Smn1tm1Jme/J
008453   B6.129-Smn1tm4(SMN2)Mrph/J
009378   B6.129-Smn1tm6(SMN2)Mrph/J
007963   B6.Cg-Smn1tm2Mrph/J
007966   B6.Cg-Smn1tm3(SMN2/Smn1)Mrph/J
008629   B6.Cg-Tg(SMN2)11Tro Smn1tm1Msd/J
008631   B6.Cg-Tg(SMN2)11Tro Tg(SMN2)46Tro Smn1tm1Msd/J
008630   B6.Cg-Tg(SMN2)46Tro Smn1tm1Msd/J
007246   B6;129-Smn1tm2Mrph/J
008383   B6;129-Smn1tm4(SMN2)Mrph/J
008704   B6;129-Smn1tm6(SMN2)Mrph/J
006138   FVB.129(B6)-Smn1tm1Jme/J
008713   FVB.129(B6)-Smn1tm4(SMN2)Mrph/J
005058   FVB.Cg-Smn1tm1Hung Tg(SMN2)2Hung/J
016573   FVB.Cg-Smn1tm1Msd Tg(S100B-EGFP)1Wjt Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb/J
008209   FVB.Cg-Smn1tm1Msd Tg(ACTA1-SMN)69Ahmb Tg(SMN2)89Ahmb/J
008206   FVB.Cg-Smn1tm1Msd Tg(SMN2)566Ahmb/J
008782   FVB.Cg-Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*A111G)588Ahmb/J
009134   FVB.Cg-Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*A111G)591Ahmb/J
006214   FVB.Cg-Smn1tm1Msd/J
007955   FVB.Cg-Smn1tm2Mrph/J
007964   FVB.Cg-Smn1tm3(SMN2/Smn1)Mrph/J
009381   FVB.Cg-Smn1tm6(SMN2)Mrph/J
005024   FVB.Cg-Tg(SMN2)89Ahmb Smn1tm1Msd/J
005026   FVB.Cg-Tg(SMN2)89Ahmb Tg(SMN1*A2G)2023Ahmb Smn1tm1Msd/J
005025   FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd/J
013574   FVB/N-Tg(149m19)M141Kunst/J
017596   STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#aAhmb/J
017597   STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#bAhmb/J
007022   STOCK Mnx1tm4(cre)Tmj Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008203   STOCK Smn1tm1Msd Tg(ACTA1-SMN)63Ahmb Tg(SMN2)89Ahmb/J
006570   STOCK Smn1tm1Msd Tg(Hlxb9-GFP)1Tmj Tg(SMN2)89Ahmb/J
006553   STOCK Smn1tm1Msd Tg(H2-K1-tsA58)6Kio Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008212   STOCK Smn1tm1Msd Tg(Prnp-SMN)92Ahmb Tg(SMN2)89Ahmb/J
007951   STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J
008783   STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Tg(CAG-cre/Esr1*)5Amc/J
View Strains carrying other alleles of Smn1     (37 strains)

Additional Web Information

Reference Guide to Mouse Models of Spinal Muscular Atrophy manual [.pdf]
Visit the Spinal Muscular Atrophy (SMA) Mouse Model Resource site for helpful information on SMA Disease and research resources.

Phenotype

Phenotype Information

View Related Disease (OMIM) Terms

Related Disease (OMIM) Terms provided by MGI
- Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
Spinal Muscular Atrophy, Type II; SMA2
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested.
Spinal Muscular Atrophy, Type III; SMA3   (SMN1)
Spinal Muscular Atrophy, Type IV; SMA4   (SMN1)
View Mammalian Phenotype Terms

Mammalian Phenotype Terms provided by MGI
      assigned by genotype

Smn1tm5(Smn1/SMN2)Mrph/Smn1tm5(Smn1/SMN2)Mrph

        FVB.129(B6)-Smn1tm5(Smn1/SMN2)Mrph/J
  • skeleton phenotype
  • decreased bone mineral content
    • 6 month old mutants exhibit lower bone mineral content   (MGI Ref ID J:186987)
  • decreased bone mineral density
    • 6 month old mutants exhibit lower bone mineral density   (MGI Ref ID J:186987)

The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.

Smn1tm5(Smn1/SMN2)Mrph/Smn1+

        involves: 129S6/SvEvTac * C57BL/6NTac
  • no phenotypic analysis
  • *normal* no phenotypic analysis
    • no phenotypic analysis available   (MGI Ref ID J:135425)

Smn1tm5(Smn1/SMN2)Mrph/Smn1tm5(Smn1/SMN2)Mrph

        involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac
  • growth/size phenotype
  • decreased body size
    • by P15 and P20, males and females, respectively, are smaller than wild-type controls   (MGI Ref ID J:186987)
  • cellular phenotype
  • necrosis
    • mutants present with progressive necrosis of peripheral body parts beginning with the tail and moving toward the hindlimbs and then to the pinnae of the ears   (MGI Ref ID J:186987)
    • onset of tail necrosis is seen as early as P5 and progresses to complete loss of the tail by 45 days of age   (MGI Ref ID J:186987)
    • tail necrosis at 20-40 days of age is characterized by disorganization of muscle fiber bundles along with loss of intact vasculature in the absence of an inflammatory lesion as mice age   (MGI Ref ID J:186987)
  • muscle phenotype
  • decreased skeletal muscle fiber size   (MGI Ref ID J:186987)
  • behavior/neurological phenotype
  • enhanced coordination
    • mutants perform better than controls on the accelerated rotarod test and marginally better on the constant speed rotarod test at 1 month of age   (MGI Ref ID J:186987)
    • however, forelimb grip strength is normal at 24 and 52 weeks of age   (MGI Ref ID J:186987)
  • hyperalgesia   (MGI Ref ID J:186987)
    • decreased thermal nociceptive threshold
      • 6-8 week old mutants (with no paw necrosis) exhibit an increase in sensitivity to moderately noxious heat with a significant decrease in hindpaw withdrawal latencies when placed on a 45C and 48C metal plate, however no differences in response to high noxious stimulus of 52C is seen   (MGI Ref ID J:186987)
      • 6-8 week old mutants exhibit robust sensitization in the evaporative cooling assay, responding more vigorously than controls, indicating increased sensitivity to temperature   (MGI Ref ID J:186987)
    • hyperresponsive to tactile stimuli
      • in plantar von Frey testing, 6-8, 20 and 24 week old mutants show significantly lower paw withdrawal force than controls, indicating hyperalgesia   (MGI Ref ID J:186987)
  • cardiovascular system phenotype
  • abnormal blood vessel morphology
    • thermal imaging indicates that vascular destruction in the tail occurs before overt exterior necrosis   (MGI Ref ID J:186987)
    • lateral vasculature of the tail is primarily affected, with a loss of integrity in the vessel wall (most evident in the inner tunica intima of the small lateral vasculature) whereas the ventral artery remains intact until the very last stages of necrosis   (MGI Ref ID J:186987)
  • decreased heart rate
    • 9 month old mutants exhibit lower average heart rate than controls   (MGI Ref ID J:186987)
    • however, mutants do not exhibit a longer PR or QRS interval, indicating that mutants do not exhibit bradyarrhythmia   (MGI Ref ID J:186987)
  • integument phenotype
  • hyperalgesia   (MGI Ref ID J:186987)
    • decreased thermal nociceptive threshold
      • 6-8 week old mutants (with no paw necrosis) exhibit an increase in sensitivity to moderately noxious heat with a significant decrease in hindpaw withdrawal latencies when placed on a 45C and 48C metal plate, however no differences in response to high noxious stimulus of 52C is seen   (MGI Ref ID J:186987)
      • 6-8 week old mutants exhibit robust sensitization in the evaporative cooling assay, responding more vigorously than controls, indicating increased sensitivity to temperature   (MGI Ref ID J:186987)
    • hyperresponsive to tactile stimuli
      • in plantar von Frey testing, 6-8, 20 and 24 week old mutants show significantly lower paw withdrawal force than controls, indicating hyperalgesia   (MGI Ref ID J:186987)
  • nervous system phenotype
  • abnormal neuromuscular synapse morphology
    • at P90, about 10% of neuromuscular junctions (NMJs) in splenius, longissimus, and semispinalis muscles show abnormal morphology, with fragmented acetylcholine receptor clusters, abnormal thin nerve terminals, some junctions innervated by multiple nerve terminals, and nerve terminal sprouting, indicating that synaptic maintenance is mildly disrupted   (MGI Ref ID J:186987)
    • however, at P8 and P14, all NJMs are innervated and no nerve sprouting is seen, indicating that synapse formation at the NJM is not affected in mutants   (MGI Ref ID J:186987)
  • abnormal synaptic transmission
    • reduction in synaptic transmission efficacy in muscle   (MGI Ref ID J:186987)
    • however, mutants exhibit normal number of motor axons in the lumbar 3 and lumbar 4 ventral roots at P350 and no significant loss of VGLUT1-positive synapses in L1-2 motoneurons   (MGI Ref ID J:186987)
    • abnormal endplate potential
      • at P90, about 8% of junctions in splenius muscle are silent, where MEPPs could be recorded, but nerve stimulation did not elicit endplate potentials (EPPs)   (MGI Ref ID J:186987)
      • at P350, 15% of junctions in splenius muscles are silent in the functional junctions that remain   (MGI Ref ID J:186987)
    • abnormal miniature endplate potential
      • at P90 and P350, muscle exhibits a slight increase in the spontaneous miniature endplate potential (MEPP) amplitude   (MGI Ref ID J:186987)
      • upon nerve stimulation, the quantal content is decreased by 13-14% in both mutants at P90 and P350   (MGI Ref ID J:186987)
      • however, no difference from controls is seen in the MEPP frequency or the evoked endplate potential (EPP) amplitudes   (MGI Ref ID J:186987)

Smn1tm5(Smn1/SMN2)Mrph/Smn1tm5(Smn1/SMN2)Mrph

        B6.129-Smn1tm5(Smn1/SMN2)Mrph/J
  • skeleton phenotype
  • decreased bone mineral content
    • 6 month old mutants exhibit lower bone mineral content   (MGI Ref ID J:186987)
  • decreased bone mineral density
    • 6 month old mutants exhibit lower bone mineral density   (MGI Ref ID J:186987)
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Neurobiology Research
Spinal Muscular Atrophy (SMA)

Genes & Alleles

Gene & Allele Information provided by MGI

 
Allele Symbol Smn1tm5(Smn1/SMN2)Mrph
Allele Name targeted mutation 5, Andrew Murphy
Allele Type Targeted (knock-in)
Common Name(s) Smn allele C;
Mutation Made By Andrew Murphy,   Regeneron Pharmaceuticals, Inc.
Strain of Origin(129S6/SvEvTac x C57BL/6NTac)F1
ES Cell Line NameF1H4
ES Cell Line Strain(129S6/SvEvTac x C57BL/6NTac)F1
Expressed Gene Smn1, survival motor neuron 1, mouse, laboratory
Expressed Gene SMN2, survival of motor neuron 2, centromeric, human
Molecular Note The allele encodes two coding sequences: the first is a hybrid gene in which a 2.2 kb segment of mouse genome containing exons 7 and 8 of the mouse Smn1 gene was replaced with a 1.3 kb fragment of human genomic DNA containing exons 7 and 8 of the human SMN2 gene and the second is a full 42 kb copy of the human SMN2 gene. A selection cassette located downstream from the human SMN2 polyadenylation signal was removed by FLPe expression in ES cells leaving a FRT site at the downstream junction between human and mouse DNA. Because exon 7 is derived from human SMN2, it is skipped in approximately 90% of the processed mRNA derived from both genes. 2 independent clones for this allele were generated and clone A2 was used to generated mice. [MGI Ref ID J:135425]
 

Genotyping

Genotyping Information

Genotyping Protocols

Generic LacZ Melt Curve Analysis, Melt Curve Analysis
Tg(SMN2*delta7)4299Ahmb, QPCR
Smn1tm5(Smn1/SMN2)Mrph, Melt Curve Analysis
Smn1tm5(Smn1/SMN2)Mrph, Standard PCR


Helpful Links

Genotyping resources and troubleshooting

References

References provided by MGI

Selected Reference(s)

Osborne M; Gomez D; Feng Z; McEwen C; Beltran J; Cirillo K; El-Khodor B; Lin MY; Li Y; Knowlton WM; McKemy DD; Bogdanik L; Butts-Dehm K; Martens K; Davis C; Doty R; Wardwell K; Ghavami A; Kobayashi D; Ko CP; Ramboz S; Lutz C. 2012. Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models. Hum Mol Genet :. [PubMed: 22802075]  [MGI Ref ID J:186987]

Additional References

Smn1tm5(Smn1/SMN2)Mrph related

Murphy A (Regeneron Pharmaceuticals, Inc.). 2008. Smn allele C. Personal Communication :.  [MGI Ref ID J:135425]

Health & husbandry

Health & Colony Maintenance Information

Animal Health Reports

Room Number           AX12

Colony Maintenance

Breeding & HusbandryWhen maintaining a live colony, these mice can be bred as heterozygotes.
Mating SystemHomozygote x Heterozygote         (Female x Male)   05-MAR-12
Diet Information LabDiet® 5K52/5K67

Pricing and Purchasing

Pricing, Supply Level & Notes, Controls


Pricing for USA, Canada and Mexico shipping destinations View International Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $232.00Female or MaleHeterozygous for Smn1tm5(Smn1/SMN2)Mrph  
$232.00Female or MaleHomozygous for Smn1tm5(Smn1/SMN2)Mrph  
Price per Pair (US dollars $)Pair Genotype
$464.00Homozygous for Smn1tm5(Smn1/SMN2)Mrph x Heterozygous for Smn1tm5(Smn1/SMN2)Mrph  

Standard Supply

Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.

Pricing for International shipping destinations View USA Canada and Mexico Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $301.60Female or MaleHeterozygous for Smn1tm5(Smn1/SMN2)Mrph  
$301.60Female or MaleHomozygous for Smn1tm5(Smn1/SMN2)Mrph  
Price per Pair (US dollars $)Pair Genotype
$603.20Homozygous for Smn1tm5(Smn1/SMN2)Mrph x Heterozygous for Smn1tm5(Smn1/SMN2)Mrph  

Standard Supply

Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.

View USA Canada and Mexico Pricing View International Pricing

Standard Supply

Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.

Control Information

  Control
   Wild-type from the colony
   001800 FVB/NJ
 
  Considerations for Choosing Controls
  Control Pricing Information for Genetically Engineered Mutant Strains.
 

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.


See Terms of Use tab for General Terms and Conditions


The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering Information
JAX® Mice
Surgical and Preconditioning Services
JAX® Services
Customer Services and Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form

Terms of Use

Terms of Use


General Terms and Conditions


For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.

Contact information

General inquiries regarding Terms of Use

Contracts Administration

phone:207-288-6470
fax:207-288-6655

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.


(6.2)